Wong KK, Piert M. Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications. J Nucl Med. 2013 Apr;54(4):590-9.
Moore AE, Blake GM, Fogelman I. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling. J Nucl Med. 2008 Mar;49(3):375-82.
Blake GM, Siddique M, Frost ML, Moore AE, Fogelman I. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover? Bone. 2011 Sep;49(3):537-42.
Yee CA, Lee HB, Blaufox MD. Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors. J Nucl Med. 1981 Dec;22(12):1054-8.
Ritchie G, Wilkinson AG, Prescott RJ. Comparison of differential renal function using technetium-99m mercaptoacetyltriglycine (MAG3) and technetium-99m dimercaptosuccinic acid (DMSA) renography in a paediatric population. Pediatr Radiol. 2008 Aug;38(8):857-62.
Weyer K, Nielsen R, Petersen SV, Christensen EI, Rehling M, Birn H. Renal uptake of 99mTc-dimercaptosuccinic acid is dependent on normal proximal tubule receptor-mediated endocytosis. J Nucl Med. 2013 Jan;54(1):159-65.
Müller-Surr R, Prigent A. Radiopharmaceuticals: their intrarenal handling and localization. In: Ell PJ, Gambhir SS. Nuclear Medicine in clinical diagnosis and treatment. 3rd ed. Edinburgh: Churchill Livingstone; 2005. P. 1501-15.
Arora G, Damle NA, Tripathi M, Bal C, Kumar P. Vicarious visualization of gall bladder on Tc-99m ethylene dicysteine renal dynamic study. Indian J Nucl Med. 2012 Oct;27(4):257-8.